Literature DB >> 21681373

Increased prevalence of regulatory T cells in the lung cancer microenvironment: a role of thymic stromal lymphopoietin.

Hui Li1, Hua Zhao, Jinpu Yu, Yanjun Su, Shui Cao, Xiumei An, Xiubao Ren.   

Abstract

Expansion of CD4+CD25+ regulatory T cells (Tregs) in tumor microenvironment was one of the mechanisms by which cancer cells escaped host defense. Thymic stromal lymphopoietin (TSLP) contributes to the generation of natural Tregs in thymus. Therefore, the purpose of this report was to investigate the role of TSLP in the increasing prevalence of Tregs in lung cancer microenvironment. The expression ratio of TSLP protein in tumor tissues was significantly increased compared with that in benign lesion and non-cancer lung tissue. The prevalence of Tregs in tumor microenvironment was correlated with the expression of TSLP in lung cancer. Dendritic cells (DCs) were induced from peripheral blood mononuclear cells (PBMCs) collected from lung cancer patients and left unstimulated (imDCs) or exposed to hTSLP (TSLP-DCs) or LPS (LPS-DCs). TSLP-DCs expressed intermediate levels of CD83 and high levels of CD86, CD11C, and HLA-DR, which showed a characteristic of less mature DCs. TSLP-DCs secreted low levels of IL-6, IL-12, IL-10, TNF-α and IFN-γ, and high levels of TGF-β and MDC. The percentage of Tregs in CD4+CD25- T cells cocultured with TSLP-DCs group was statistically higher than that of LPS-DCs and imDCs. Transwell assays showed that TSLP-DCs exhibited increased ability to attract the migration of CD4+CD25- Tregs, when compared with imDCs. These results indicated that TSLP proteins were expressed in lung tumor tissue and correlated with the prevalence of Tregs. TSLP-DCs could induce CD4+CD25- T cells to differentiate into CD4+CD25+foxp3+ T cells and the migration of CD4+CD25+ T cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21681373     DOI: 10.1007/s00262-011-1059-6

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  19 in total

Review 1.  Functions of thymic stromal lymphopoietin in immunity and disease.

Authors:  Yanlu Zhang; Baohua Zhou
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  Evaluation of thymic stromal lymphopoietin (TSLP) and its correlation with lymphatic metastasis in human gastric cancer.

Authors:  Roghayeh Barooei; Reihaneh Alsadat Mahmoudian; Mohammad Reza Abbaszadegan; Atena Mansouri; Mehran Gholamin
Journal:  Med Oncol       Date:  2015-07-15       Impact factor: 3.064

Review 3.  Mechanisms of immune response regulation in lung cancer.

Authors:  Joanna Domagala-Kulawik; Iwona Osinska; Grazyna Hoser
Journal:  Transl Lung Cancer Res       Date:  2014-02

4.  Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma.

Authors:  Roniel Cabrera; Miguel Ararat; Yiling Xu; Todd Brusko; Clive Wasserfall; Mark A Atkinson; Lung Ji Chang; Chen Liu; David R Nelson
Journal:  Cancer Immunol Immunother       Date:  2012-12-07       Impact factor: 6.968

5.  TSLP Expression and High Serum TSLP Level Indicate a Poor Prognosis in Gastric Cancer Patients.

Authors:  Joji Watanabe; Hiroaki Saito; Kozo Miyatani; Masahide Ikeguchi; Yoshihisa Umekita
Journal:  Yonago Acta Med       Date:  2015-10-14       Impact factor: 1.641

6.  The role of Foxp3 and Tbet co-expressing Treg cells in lung carcinoma.

Authors:  Katerina Kachler; Corinna Holzinger; Denis I Trufa; Horia Sirbu; Susetta Finotto
Journal:  Oncoimmunology       Date:  2018-04-25       Impact factor: 8.110

7.  Defect in recruiting effector memory CD8+ T-cells in malignant pleural effusions compared to normal pleural fluid.

Authors:  Arnaud Scherpereel; Bogdan Dragos Grigoriu; Marc Noppen; Thomas Gey; Bachar Chahine; Simon Baldacci; Jacques Trauet; Marie-Christine Copin; Jean-Paul Dessaint; Henri Porte; Myriam Labalette
Journal:  BMC Cancer       Date:  2013-07-02       Impact factor: 4.430

8.  Plasmacytoid DCs, exposed to TSLP in synergy with TLR ligands, acquire significant potential towards Th2 polarization.

Authors:  Jana Kopecka; Daniela Rozkova; Anna Sediva
Journal:  Med Sci Monit Basic Res       Date:  2013-12-13

9.  Therapeutical measures to control airway tolerance in asthma and lung cancer.

Authors:  Katerina Andreev; Anna Graser; Anja Maier; Stephanie Mousset; Susetta Finotto
Journal:  Front Immunol       Date:  2012-07-26       Impact factor: 7.561

Review 10.  Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment.

Authors:  Marlies E Heuvers; Joachim G Aerts; Robin Cornelissen; Harry Groen; Henk C Hoogsteden; Joost P Hegmans
Journal:  BMC Cancer       Date:  2012-12-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.